Inventor · disambiguated record
Patrick Dougherty
Also filed as: DOUGHERTY PATRICK · DOUGHERTY PATRICK G
4 granted patents·7 pending applications·11 citations·filing 2019–2023
67Inventor score
Top patents by PatentIndex Score
11 records- 0189US11576946B2Peptidyl inhibitors of calcineurin-NFAT interactionOHIO STATE INNOVATION FOUNDATION·Filed 2019·Granted Feb 14, 2023·8 cites·21 claims
- 0287US11793884B2Cyclic peptidyl inhibitors of CAL-PDZ binding domainOHIO STATE INNOVATION FOUNDATION·Filed 2019·Granted Oct 24, 2023·3 cites·8 claims
- 0373US12496350B2Cyclic peptidyl inhibitors of CAL-PDZ binding domainOHIO STATE INNOVATION FOUNDATION·Filed 2023·Granted Dec 16, 2025·0 cites·19 claims
- 0466US12329799B2Peptidyl inhibitors of calcineurin-NFAT interactionOHIO STATE INNOVATION FOUNDATION·Filed 2023·Granted Jun 17, 2025·0 cites·20 claims
- 0566US2025011774A1Antisense compounds and methods for targeting cug repeatsENTRADA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0660US2025289851A1Cyclic peptides for delivering therapeuticsENTRADA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0759US2024245790A1Cyclic cell penetrating peptidesENTRADA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0858US2023312653A1Cyclic cell penetrating peptidesENTRADA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0958US2023027739A1Antigen-binding and antigen degradation constructsENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1057US2024358845A1Compositions and methods for intracellular therapeuticsENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1154US2025243244A1Cyclic cell penetrating peptidesENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrick Dougherty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →